BlackRock Investment Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.88M Buy
99,002
+3,765
+4% +$72K ﹤0.01% 2253
2016
Q3
$1.86M Buy
95,237
+23,763
+33% +$402K ﹤0.01% 2218
2016
Q2
$1.07M Buy
71,474
+20,734
+41% +$261K ﹤0.01% 2578
2016
Q1
$467K Buy
50,740
+1,416
+3% +$17.2K ﹤0.01% 2929
2015
Q4
$950K Buy
49,324
+124
+0.3% +$2.15K ﹤0.01% 2637
2015
Q3
$731K Buy
49,200
+187
+0.4% +$4.39K ﹤0.01% 2834
2015
Q2
$1.07M Buy
49,013
+31,455
+179% +$634K ﹤0.01% 2717
2015
Q1
$395K Buy
17,558
+1,157
+7% +$26.8K ﹤0.01% 3046
2014
Q4
$331K Buy
16,401
+3,110
+23% +$56.4K ﹤0.01% 3163
2014
Q3
$243K Sell
13,291
-246
-2% -$3.56K ﹤0.01% 3215
2014
Q2
$182K Buy
13,537
+2,498
+23% +$34.1K ﹤0.01% 3239
2014
Q1
$182K Buy
+11,039
New +$191K ﹤0.01% 3244

Other funds holding FLXN